• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:BR112012001642B1
    申请号:R112012001642
    申请日:2010-07-23
    公开日:2018-09-11
    发明作者:Jeroen Adriaan Van Maris Antonius；Thomas Pronk Jacobus；Gabriel Guadalupe Medina Victor
    申请人:Dsm Ip Assets Bv；Univ Delft Tech；
    IPC主号:
    专利说明:

    (54) Title: TRANSGENIC YEAST CELLS AND METHOD FOR PREPARING ETHANOL A
    FROM ACETATE AND A FERMENTABLE CARBOHYDRATE (51) Int.CI .: C12N 1/18; C12N 9/02; C12P 7/06; C12P 7/10; C12N 15/53 (30) Unionist Priority: 24/07/2009 EP 09166360.9 (73) Holder (s): DSM IP ASSETS B.V.
    (72) Inventor (s): JACOBUS THOMAS PRONK; ANTONIUS JEROEN ADRIAAN VAN MARIS; VICTOR GABRIEL GUADALUPE MEDINA (85) National Phase Start Date: 24/01/2012
    1/54 “TRANSGENIC YEAST CELLS AND METHOD FOR PREPARING ETHANOL FROM ACETATE AND A FERMENTABLE CARBOHYDRATE” [001] The present invention relates to a recombinant yeast cell with the ability to produce a desired fermentation product, the construction of the said yeast cell by genetic modification and a process for synthesizing a fermentation product, wherein said yeast cell is used.
    [002] Ethanol production by Saccharomyces cerevisiae is currently, by volume, the largest fermentation process in industrial biotechnology. A global research effort is underway to expand the substrate range of S. cerevisiae to include lignocellulosic hydrolysates, in particular hydrolyzed lignocellulosic biomass from non-food raw materials (eg energy agricultural crops and agricultural waste, forestry waste or waste materials industry / consumer products that are rich in cellulose, hemicellulose and / or pectin), and to increase productivity, abundance and product yield.
    [003] Lignocellulosic biomass is abundant, however, in general it is not easily fermented by ethanol-producing wild type microorganisms, such as S. cerevisiae. The biomass has to be hydrolyzed. The resulting hydrolyzate is often a mixture of several monosaccharides and oligosaccharides, which may not all be suitable substrates for the wild type microorganism. In addition, hydrolysates typically comprise the acetic acid formed as a by-product, in particular during the hydrolysis of pectin or hemicellulose
    2/54 and, depending on the type of hydrolysis, one or more other by-products or residual reagents that may adversely affect fermentation. In particular, it is reported that acetic acid negatively affects the kinetics and / or stoichiometry of sugar fermentation by wild-type and genetically modified strains of S. cerevisiae, and its toxicity is greatly increased in low pH cultivation (Helle et al. Enzyme Microb Technol 33 (2003) 786-792; Bellissimi et al. FEMS Yeast Res 9 (2009) 358-364).
    [004] Several approaches have been proposed to improve the fermentative properties of ethanol-producing organisms by genetic modification, and to improve the hydrolysis process of biomass. For example, a development perspective on fermentative ethanol production from hydrolysates is provided in a review by A. van Maris et al. (Antonie van Leeuwenhoek (2006) 90: 391-418). Reference is made to various ways in which S. cerevisiae can be modified and to various methods of hydrolyzing lignocellulosic biomass.
    [005] A major challenge with regard to stoichiometry in the production of yeast-based ethanol is that substantial amounts of glycerol are invariably formed as a by-product. It is estimated that, in typical industrial ethanol processes, up to about 4%
    by weight of the matter cousin of sugar be converted in glycerol (Nissen et al. Yeast 16 (2000) 463-474). In conditions that are ideal for the growth anaerobic, The conversion in glycerol can to be even higher, up to about 10
    O, % .
    [006] Glycerol production under anaerobic conditions
    3/54 is mainly linked to redox metabolism. During the anaerobic growth of S. cerevisiae, the dissimilation of sugar occurs through alcoholic fermentation. In this process, the NADH formed in the glycolytic reaction of glyceraldehyde-3-phosphate dehydrogenase is reoxidized by converting the acetaldehyde formed by pyruvate decarboxylation into ethanol by means of NAD + -dependent alcohol dehydrogenase. Fixed stoichiometry of this redox-neutral dissimilatory pathway causes problems when a net reduction of NAD + in NADH occurs at any stage in metabolism. Under anaerobic conditions, the reoxidation of NADH in S. cerevisiae is strictly dependent on the reduction of sugar in glycerol. Glycerol formation is initiated by reducing the glycolytic intermediate dihydroxyacetone phosphate to glycerol 3-phosphate, a reaction catalyzed by NAD + -dependent glycerol 3-phosphate dehydrogenase. Subsequently, the glycerol 3-phosphate formed in this reaction is hydrolyzed by glycerol-3-phosphatase to yield glycerol and inorganic phosphate. Consequently, glycerol is an important by-product during anaerobic production of ethanol by S. cerevisiae, which is not desired since it completely reduces the conversion of sugar to ethanol. Additionally, the presence of glycerol in effluents from ethanol production plants can impose costs for the treatment of wastewater.
    [007] It is an objective of the invention to provide an unprecedented recombinant cell, which is suitable for the anaerobic fermentative production of ethanol from a carbohydrate, in particular a carbohydrate obtained from lignocellulosic biomass, which presents a production
    4/54 reduced glycerol compared to the corresponding wild type organism or that needs glycerol production if the cell is used for fermentative ethanol preparation.
    [008] It is an additional objective to provide an unprecedented method for fermentably preparing ethanol in anaerobic yeast cultures, in which method no glycerol is formed, or at least in which less glycerol is formed than in a method that makes use of known strains of S. cerevisiae.
    [009] One or more additional objectives that can be achieved are evident from the description and / or claims.
    [010] The inventors understand that it is possible to achieve one or more of these objectives by providing a specific recombinant cell, in which another specific enzymatic activity has been incorporated, which allows the reoxidation of NADH formed in the fermentation of a carbohydrate also in the absence of enzymatic activity necessary for the synthesis of NADH-dependent glycerol.
    [011] Accordingly, the present invention relates to a recombinant yeast cell, the cell comprising one or more recombinant nucleic acid sequences, in particular one or more heterologous nucleic acid sequences that encode an acetyldehyde-dependent acetyldehyde dehydrogenase activity NAD + (EC 1.2.1.10).
    [012] The inventors have understood, in particular, that it is advantageous to provide a cell with no enzyme activity necessary for the synthesis of NADH-dependent glycerol, or a cell with reduced enzyme activity required
    5/54 for the synthesis of NADH-dependent glycerol.
    [013] Thus, the invention relates in particular to a recombinant yeast cell comprising one or more heterologous nucleic acid sequences that encode an NAD + -dependent acetyldehyde acetaldehyde activity, in which the cell lacks the necessary enzyme activity for the synthesis of NADH-dependent glycerol (that is, it is free of such activity), or in which the cell has a reduced enzymatic activity in relation to the synthesis of NADH-dependent glycerol, compared to the corresponding wild-type yeast cell.
    [014] The invention further relates to the use of a cell, according to the invention, for the preparation of ethanol.
    [015] In particular, the invention relates in addition to a method for preparing ethanol, comprising preparing ethanol from a fermentable carbohydrate and acetate, the preparation of which is carried out under anaerobic fermentative conditions using a yeast cell, said cell expressing the activity of acetylCoenzyme The synthetase and the activity of acetyldehyde acetaldehyde dehydrogenase dependent on NAD + , said cell preferably without the necessary enzymatic activity with respect to the biochemical pathway for the synthesis of glycerol from a carbohydrate, or with a reduced enzyme activity with respect to to the biochemical pathway for glycerol synthesis from a carbohydrate, compared to a wild type cell of S. cerevisiae.
    [016] Advantageously, according to the invention, the
    6/54 ethanol is produced in a molar ratio of glycerol: ethanol less than 0.04: 1, in particular less than 0.02: 1, preferably less than 0.01: 1. Glycerol production may be absent (undetectable), although at least in some modalities (where NADH-dependent glycerol synthesis is reduced, but is not completely prohibited) some glycerol may be produced as a by-product, for example. example, in a glycerol to ethanol ratio of 0.001: 1 or more.
    [017] Figure 1 schematically shows a genetic modification procedure that can be performed as part of the production of a cell according to the invention.
    [018] Figure 2 shows concentrations of biomass and products in anaerobic cultures in lots of different strains of S. cerevisiae in glucose (20 g L -1 ). Acetic acid (2.0 g L -1 ) emerged from the start of fermentation (panel A, B) or was added at the time point indicated by the arrow (panel C, D). Growth conditions: T = 30 ° C, pH 5.0. Symbols: A, optical density at 660 nm; ·, glucose; o, ethanol; · acetate; □, glycerol. Each graph represents values from two independent replicates, yielding data that differ by less than 5%. Panel A: S. cerevisiae IME076 (GPD1 GPD2). Panel B: S. cerevisiae IMZ132 (GPD1A gpd2A that overexpresses the E. coli mhpF gene). Panel C: S. cerevisiae IMZ132 (GPD1A gpd2A which overexpresses the E. coli mhpF gene). Panel D: S. cerevisiae IMZ127 (GPD1A gpd2A) grown in glucose (20 gL -1 ).
    [019] The present invention allows the elimination
    7/54 complete glycerol production, or at least a significant reduction of it, providing a recombinant yeast cell, in particular S. cerevisiae, in such a way that it can reoxidate NADH by reducing acetic acid in ethanol, through reactions dependent on NADH.
    [020] This is not advantageous only when glycerol production is avoided or at least reduced, but since the product formed on the reoxidation of NADH is also the desired product, ie ethanol, a method of the invention can also offer a higher product yield (determined as the% by weight of the converted raw material, that is, carbohydrate and acetic acid, which is converted into ethanol).
    [021] Since acetic acid is generally available in significant amounts of lignocellulosic hydrolysates, this makes the present invention particularly advantageous for the preparation of ethanol using lignocellulosic biomass as a source for fermentable carbohydrate. In addition, carbohydrate sources that may contain a considerable amount of acetate include beet molasses (hydrolysates) and that contain starch (for example, waste products from dry corn milling processes, from wet corn milling processes; starting from residual starch processes, for example, with distillery waste recycling). The invention contributes to a decrease in the levels of the acetic acid inhibiting compound, and a greater fraction of the hydrolyzate effectively becomes a substrate for the production of ethanol.
    [022] Good results have been achieved with a cell
    8/54 yeast without remarkable enzymatic activity required for the synthesis of NADH-dependent glycerol, as illustrated in the example. However, the inventors also contemplate that a yeast cell, according to the invention, with NADH-dependent glycerol synthesis activity can be advantageously used, for example, for the production of ethanol. It is contemplated that such a cell can use acetate to reoxidize at least part of the NADH. As a result, acetate can compete with the NADH-dependent glycerol synthesis pathway and thus potentially reduce glycerol synthesis. Furthermore, the acetate present in a raw material used for the production of ethanol, such as a lignocellulosic hydrolyzate, can be converted into ethanol, thereby increasing the yield of the product.
    [023] The term one or one, as used herein, is defined as at least one, unless otherwise specified.
    [024] When referring to a noun (for example, a compound, an additive, etc.) in the singular, it means that the plural is included. Thus, when referring to a specific fraction, for example, compound, this means at least one of that fraction, for example, at least one compound, unless otherwise specified.
    [025] The term or, as used herein, should be understood as and / or.
    [026] When referring here to a carboxylate, for example, acetate, it means that the corresponding carboxylic acid (its conjugated acid), as well as a salt thereof, must be included, and vice versa.
    9/54 [027] When referring to a compound in which several isomers exist (for example, a D and a L enantiomer), the compound includes in principle all the enantiomers, diastereomers and cis / trans isomers of this compound that can be used in the particular method of the invention; in particular, when referring to the compound, it includes the natural isomer (s).
    [028] The term fermentation, fermentative and the like are used here in a classic sense, that is, to indicate whether a process is or has been carried out under anaerobic conditions. Anaerobic conditions are defined here as conditions without any oxygen. or where essentially no oxygen is consumed by the yeast cell, in particular a yeast cell, and in general corresponds to an oxygen consumption less than 5 mmol / Lh, in particular an oxygen consumption less than 2.5 mmol / Lh Lh or less than 1 mmol / Lh. This generally corresponds to a concentration of oxygen dissolved in the breeding stock less than 5% air saturation, in particular a concentration of dissolved oxygen less than 1% air saturation, or less than 0.2% air saturation.
    [029] The term yeast or yeast cell refers to a phylogenetically diverse group of single cell fungi, most of which are in the Ascomycota and Basidiomycota division. Sprouting yeasts (true yeasts) are classified in the order Saccharomycetales, with Saccharomyces cerevisiae as the most well-known species.
    [030] The term recombinant (cell), as used herein, refers to a strain (cell) that contains acid
    10/54 nucleic acid, which is the result of one or more genetic modifications using recombinant DNA technique (s) and / or one or more other mutagenic technique (s). In particular, a recombinant cell can comprise nucleic acid that is not present in a corresponding wild type cell, whose nucleic acid was introduced into this strain (cell) using recombinant DNA techniques (a transgenic cell), or whose nucleic acid is not present in the said wild type cell is the result of one or more mutations, for example, using recombinant DNA techniques or another mutagenesis technique, such as UV irradiation, in a nucleic acid sequence present in said wild type cell (such as a gene encoding a wild-type polypeptide), or where the nucleic acid sequence of a gene has been modified to target the polypeptide product (encoding it) in another cell compartment. Additionally, the term (cell)
    recombinant says respect in particular to a strain (cell) from of which at DNA sequences were removed using techniques of DNA recombinant. [031] The term cell transgenic (yeast) , gives
    As used herein, it refers to a strain (cell) that contains the non-naturally occurring nucleic acid in this strain (cell) and that was introduced into this strain (cell) using recombinant DNA techniques, that is, a recombinant cell).
    [032] The term mutated, as used herein, with respect to proteins or polypeptides, means that at least one amino acid in the sequence of wild-type or naturally occurring proteins or polypeptides has been
    11/54 replaced by a different amino acid, inserted or deleted from the sequence by mutagenesis of nucleic acids that encode these amino acids. Mutagenesis is a method well known in the art and includes, for example, site-directed mutagenesis by PCR or by oligonucleotide-mediated mutagenesis, as described in Sambrook et al., Molecular Cloning- A Laboratory Manual, 2nd ed. , Vol. 1-3 (1989). The term mutated, as used herein with respect to genes, means that at least one nucleotide in the nucleic acid sequence of this gene, or a regulatory sequence thereof, has been replaced by a different nucleotide, or has been deleted from the sequence through mutagenesis, which results in the transcription of a protein sequence with a qualitative or quantitatively altered function, or in the neutralization of this gene.
    [033] The term gene, as used herein, refers to a nucleic acid sequence that contains a template for a nucleic acid polymerase, in eukaryotes, RNA polymerase II. The genes are transcribed into RNAms which are then translated into protein.
    [034] The term nucleic acid, as used herein, includes reference to a deoxyribonucleotide or ribonucleotide polymer, that is, a polynucleotide in both single-stranded and double-stranded forms and, unless otherwise limited, includes analogs known to be of the essential nature of natural nucleotides in which they hybridize to single-stranded nucleic acids in a similar manner to naturally occurring nucleotides (for example, acids
    12/54 nucleic peptides). A polynucleotide can be full-length or a substring of a natural, structural, heterologous or regulatory gene. Unless otherwise indicated, the term includes reference to the specified sequence, as well as its complementary sequence. Thus, DNAs or RNAs with principal structures modified with respect to stability or for other reasons are polynucleotides, as the term is intended here. Furthermore, DNAs or RNAs that comprise unusual bases such as inosine, or modified bases such as tritylated bases, to name just two examples, are polynucleotides as used herein. It is understood that a wide variety of modifications have been made to DNA and RNA that serve many of the purposes used by those skilled in the art. The term polynucleotide, as used herein, includes such chemical, enzymatic or metabolically modified forms of polynucleotides, as well as the chemical forms characteristic of DNA and RNA of viruses and cells, including, among other things, simple and complex cells.
    [035] The terms polypeptide, peptide and protein are used interchangeably here to refer to a polymer of amino acid residues. The terms apply to amino acid polymers where one or more amino acid residues is an artificial chemical analog of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers. The essential nature of such naturally occurring amino acid analogs is that, when incorporated into a protein, this protein is specifically reactive to antibodies
    13/54 elicited on the same protein, but which consist completely of naturally occurring amino acids. The terms polypeptide, peptide and protein are also inclusive of modifications including, but not limited to, glycosylation, lipid attachment, sulfation, gamma carboxylation of glutamic acid residues, hydroxylation and ADP-ribosylation.
    [036] When an enzyme is mentioned with reference to an enzyme class (EC), the enzyme class is a class into which the enzyme is classified, or can be classified, on the basis of the Enzyme Nomenclature provided by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), whose nomenclature can be found at http://www.chem.qmul.ac.uk/iubmb/enzyme/. Other suitable enzymes that have not (yet) been classified in a specific class, but can be classified as such, should be included.
    [037] If a protein or nucleic acid sequence, such as a gene, is referred to herein by reference to an accession number, this number is used in particular to refer to a protein or nucleic acid sequence (gene) with a string that can be found at www.ncbi.nlm.nih.gov/, (available July 13, 2009), unless otherwise specified.
    [038] Each nucleic acid sequence here that encodes a polypeptide, by reference to the genetic code, also describes each possible silent variation of the nucleic acid. The term conservatively modified variants applies to both sequences of
    14/54 amino acids and nucleic acids. With respect to particular nucleic acid sequences, conservatively modified variants refer to those nucleic acids that encode identical or conservatively modified variants of amino acid sequences, due to the degeneration of the genetic code. The term genetic code degeneration refers to the fact that a large number of functionally identical nucleic acids encode any given protein. For example, all codons GCA, GCC, GCG and GCU encode the amino acid alanine. Thus, at each position where an alanine is specified by a codon, the codon can be changed in any of the corresponding codons described without changing the encoded polypeptide. Such variations of nucleic acid are silent variations and represent a kind of conservatively modified variation.
    [039] The term functional homologous (or briefly homologous) of a polypeptide with a specific sequence (for example, SEQ ID NO: 2), as used herein, refers to a polypeptide that comprises said specific sequence stipulating that one or more amino acids are substituted, deleted, added and / or inserted, and which presents the polypeptide (qualitatively) the same functionality for the enzymatic conversion of substrate, e.g., a homologous acetylating acetaldehyde dehydrogenase activity - dependent NAD + (EC 1.2.1.10) is capable of converting acetaldehyde to ethanol. This functionality can be tested for use in an assay system comprising a recombinant yeast cell comprising an expression vector for the expression of
    Yeast homologous, said expression vector comprising a heterologous nucleic acid sequence operably linked to a functional promoter in yeast, and said heterologous nucleic acid sequence encoding the homologous polypeptide from which the enzyme activity to convert acetyl -Coenzyme A in acetaldehyde in the yeast cell must be tested, and assessing whether said conversion occurs in said cells. Candidate counterparts can be identified using in silico similarity analyzes. A detailed example of an analysis like this is described in example 2 of WO2009 / 013159. Those skilled in the art are able to derive from there how suitable candidate counterparts can be found and, optionally by codon (pair) optimization, will be able to test the required functionality of such candidate counterparts using a suitable test system in the manner described earlier. A suitable homologue represents a polypeptide with an amino acid sequence similar to a specific polypeptide by more than 50%, preferably by 60% or more, in particular by at least 70%, more in particular by at least 80%, at least 90% at least 95%, at least 97%, at least 98% or at least 99%, for example, with an amino acid sequence similarity like this in SEQ ID NO: 2, and with the enzymatic functionality required to convert acetyl- Coenzyme A in acetaldehyde. With respect to nucleic acid sequences, the term functional homologue should include nucleic acid sequences that differ from another nucleic acid sequence, due to the degeneration of the genetic code, and encode the same
    16/54 polypeptide sequence.
    [040] Sequence identity is defined here as a relationship between two or more amino acid sequences (polypeptides or proteins) or two or more nucleic acid sequences (polynucleotides), in the manner determined to compare the sequences. In general, sequence identities or similarities are compared to the total size of the sequences compared. In the art, identity also means the degree of sequence relationship between amino acid or nucleic acid sequences, as may be the case, as determined by the combination of strands of such sequences.
    [041] The preferred methods for determining identity are determined to provide the best match between the tested sequences. The methods for determining identity and similarity are codified in publicly available computer programs. Preferred computer program methods for determining the identity and similarity between two sequences include, for example, BestFit, BLASTP, BLASTN and FASTA (Altschul, SF et al, J. MoI. Biol. 215: 403-410 (1990) , publicly available on NCBI and other sources (BLAST Manual, Altschul, S., et al, NCBI NLM NIH Bethesda, MD 20894). Preferred parameters for comparing amino acid sequences using BLASTP are 11.0 gap gap, gap span 1, Blosum 62 matrix.
    [042] The term refers to the transcription of a gene into structural RNA (RNAr, tRNA) or messenger RNA (mRNA) with subsequent translation into a protein.
    [043] As used here, heterologous, in
    17/54 reference to a nucleic acid or protein, is a nucleic acid or protein that originates from a foreign species or, if it is from the same species, is substantially modified from its natural form in composition and / or genomic locus by deliberate human intervention. For example, a promoter operably linked to a heterologous structural gene is of a different species from that from which the structural gene was derived, or, if it is of the same species, one or both are substantially modified from its original form. A heterologous protein can originate from a foreign species or, if it is from the same species, it is substantially modified from its original form by deliberate human intervention.
    [044] The term heterologous expression refers to the expression of heterologous nucleic acids in a host cell. The expression of heterologous proteins in eukaryotic host cell systems, such as yeast, is well known to those skilled in the art. A polynucleotide that comprises a nucleic acid sequence of a gene that encodes an enzyme with a specific activity can be expressed in a eukaryotic system like this. In some embodiments, transformed / transfected yeast cells can be used as expression systems for the expression of enzymes. The expression of heterologous proteins in yeast is well known. Sherman, F., et al., Methods in Yeast Genetics, Cold Spring Harbor Laboratory (1982) is a well-recognized work that describes the various methods available for expressing proteins in yeast. Two widely used yeasts are Saccharomyces cerevisiae and Pichia
    18/54 pastoris. Vectors, strains and protocols for expression in Saccharomyces and Pichia are known in the art and available from commercial suppliers (eg, Invitrogen). Suitable vectors generally display expression control sequences, such as promoters, including 3-phosphoglycerate kinase or alcohol oxidase, and an origin of replication, termination sequences and the like in the desired manner.
    [045] As used here, the promoter is a DNA sequence that directs the transcription of a (structural) gene. Typically, a promoter is located in the 5 'region of a gene, close to the transcriptional initial site of a (structural) gene. Promoter sequences can be constitutive, inducible or repressible. If a promoter is an inducible promoter, then the rate of transcription increases in response to an inducing agent.
    [046] The term vector, as used here, includes reference to an autosomal expression vector and an integration vector used for integration into the chromosome.
    [047] The term expression vector refers to a DNA molecule, linear or circular, comprising a segment that encodes a polypeptide of interest in the control (that is, operably linked to) additional nucleic acid segments that provide its transcription . Such additional segments may include promoter and terminator sequences, and may optionally include one or more origins of replication, one or more selectable markers, an enhancer, a polyadenylation signal and the like. Expression vectors are derived in general
    19/54 of plasmid or viral DNA, or may contain elements of both. In particular, an expression vector has a nucleic acid sequence that comprises in the 5 'to 3' direction and is operably linked to: (a) a yeast-recognized translation and transcription start region, (b) a coding sequence for a polypeptide of interest, and (c) a translation completion and transcription region recognized in yeast. Plasmid refers to extrachromosomal DNA that replicates autonomously, which is not integrated into a microorganism genome, and is generally circular in nature.
    [048] An integration vector refers to a DNA molecule, linear or circular, that can be incorporated into a genome of the microorganism and provides stable hereditary characteristics of a gene that encodes a polypeptide of interest. The integration vector generally comprises one or more segments comprising a sequence of the gene that encodes a polypeptide of interest in controlling (i.e., operably linked to) additional segments of nucleic acid that provides its transcription. Such additional segments may include promoter and terminator sequences, and one or more segments that direct the incorporation of the gene of interest into the genome of the target cell, generally by the process of homologous recombination. Typically, the integration vector will be one that can be transferred to the target cell, but which has a replicon that is non-functional in this organism. The integration of the segment comprising the gene of interest can be selected if an appropriate marker is included in this
    20/54 segment.
    [049] As used herein, the term operably linked refers to a juxtaposition, in which the components thus described are in a relationship that allows them to function in their intended manner. A control sequence operably linked to another control sequence and / or a coding sequence is linked in such a way that the transcription and / or expression of the coding sequence is achieved under conditions compatible with the control sequence. In general, operably linked means that the nucleic acid sequences that are linked are contiguous and, where necessary, join two protein coding regions, contiguous and in the same reading frame.
    [050] Host cell means a cell that contains a vector and assists the replication and / or expression of the vector. Host cells can be prokaryotic cells such as E. coli, or eukaryotic cells such as yeast, insect, amphibian or mammalian cells. Preferably, the host cells are cells of the order of Actinomycetales, more preferably yeast cells, more preferably Saccharomyces cerevisiae cells.
    [051] Transformation and transforming, as used herein, refers to the insertion of an exogenous polynucleotide into a host cell, regardless of the method used for insertion, for example, direct absorption, transduction, f-type conjugation or electroporation. The exogenous polynucleotide can be maintained as an unintegrated vector, for example, a plasmid or, alternatively,
    21/54 can be integrated into the host cell genome.
    [052] A cell according to the invention is preferably selected from the group of Saccharomycetaceae, more preferably from the group of Saccharomyces cells, Zygosaccharomyces and Kluyveromyces cells. In particular, good results have been achieved with a Saccharomyces cerevisiae host cell. Zygosaccharomyces baillii is another particularly preferred cell, especially for its tolerance to high concentrations of acetate and its tolerance to high concentrations of ethanol.
    [053] Additionally, a cell according to the invention can be a yeast cell selected from the group of yeasts that ferment xylose, more preferably a species of Pichia, for example, Pichia stipitis or Pichia angusta (also known as Hansenula polymorpha).
    [054] In a further embodiment, a host cell according to the invention is a host cell that does not naturally exhibit the enzyme activity necessary for the synthesis of NADH-dependent glycerol, for example, yeast cells that belong to the species Brettanomyces intermedins.
    [055] A preferred cell, according to the invention, is free of the enzyme activity required for NADH-dependent glycerol synthesis, or has reduced enzyme activity with respect to the NADH-dependent biochemical pathway for glycerol synthesis from a carbohydrate, compared to its corresponding wild-type yeast cell.
    [056] A reduced enzyme activity can be
    22/54 achieved by modifying one or more genes that encode an NAD-dependent 3-phosphate glycerol dehydrogenase (GPD) activity, or one or more genes that encode a glycerol phosphate phosphatase (GPP) activity, in such a way that the enzyme is expresses considerably less than in the wild type, or in such a way that the gene encodes a polypeptide with reduced activity. Such modifications can be carried out using commonly known biotechnological techniques, and may include in particular one or more knock-out type mutations or site-directed mutagenesis of promoter regions or coding regions of the structural genes encoding GPD and / or GPP. Alternatively, yeast strains that are deficient in glycerol production can be obtained by random mutagenesis, followed by the selection of strains with reduced or absent GPD and / or GPP activity. The GDP1, GDP2, GPP1 and GPP2 genes of S. cerevisiae are shown in SEQ ID NO: 24-27.
    [057] Preferably, at least one gene encoding a GPD or at least one gene encoding a GPP is completely deleted, or at least a part of the gene that is deleted encodes a part of the enzyme that is essential for its activity. In particular, good results were achieved with an S. cerevisiae cell, in which the open frames for reading the GPD1 gene and the GPD2 gene were inactivated. The inactivation of a structural gene (target gene) can be performed by those skilled in the art by synthesizing synthetically, or otherwise constructing, a DNA fragment consisting of a selectable marker gene flanked by DNA sequences, which are identical to those sequences that flank the region of
    23/54 host cell genome that must be deleted. In particular, good results were obtained with the inactivation of the GPD1 and GPD2 genes in Saccharomyces cerevisiae by integrating the kanMX and hphMX4 marker genes. Subsequently, this DNA fragment is transformed into a host cell. Transformed cells that express the dominant marker gene are checked for correct replacement of the region that has been determined to be deleted, for example, by a polymerase chain reaction diagnosis or Southern type hybridization.
    [058] As indicated above, a cell according to the invention comprises a heterologous nucleic acid sequence that encodes an NAD + -dependent acetyldehyde acetaldehyde (EC 1.2.1.10). This enzyme catalyzes the conversion of acetyl-Coenzyme A to acetaldehyde. This conversion can be represented by the equilibrium reaction formula:
    acetyl-Coenzyme A + NADH + H + <-> acetaldehyde + NAD + +
    Coenzyme A.
    [059] Thus, this enzyme allows the reoxidation of NADH when acetyl-Coenzyme A is generated from the acetate present in the growth medium and, therefore, glycerol synthesis is no longer necessary to balance the redox cofactor.
    [060] The nucleic acid sequence encoding NAD + -dependent acetyldehyde acetaldehyde can originate, in principle, from any organism comprising a nucleic acid sequence encoding said dehydrogenase.
    [061] Acetylating acetaldehyde dehydrogenase
    24/54 known NAD + s-dependent that can catalyze the reduction of acetyl-Coenzyme A NADH-dependent in acetaldehyde, in general, can be divided into three types of functional homologues of NAD + -dependent acetyldehyde acetaldehyde:
    1) Bifunctional proteins that catalyze the reversible conversion of acetyl-Coenzyme A to acetaldehyde, and the subsequent reversible conversion of acetaldehyde to ethanol. An example of this type of protein is the AdhE protein in E. coli (Gen Bank No: NP_415757). AdhE appears to be the evolutionary product of a gene fusion. The NH2 terminal region of the AdhE protein is highly homologous to the aldehyde: NAD + oxidoreductases, whereas the COOH terminal region is homologous to a Fe 2+ dependent ethanol family: NAD + oxidoreductases (Membrillo-Hernandez et al., (2000 ) J. Biol. Chem. 275: 33869-33875). E. coli AdhE is subjected to metal-catalyzed oxidation and is therefore sensitive to
    oxygen (Tamarit et al. (1998) J. Biol. Chem. 273: 3027- 32). 2) Proteins what catalyze conversion reversible in acetyl-Coenzyme THE in acetaldehyde, in conditions
    strictly anaerobic or optional, but do not have alcohol dehydrogenase activity. An example of this type of
    proteins has been reported in Clostridium kluyveri (Smith et al. (1980) Arch. Biochem. Biophys. 203: 663-675). An acetaldehyde acetylating dehydrogenase was detected at the genome of Clostridium kluyveri DSM 555 (GenBank At the: EDK33116). A protein AcdH counterpart is identified at the
    genome of Lactobacillus plantarum (GenBank No: NP_784141). Another example of this type of protein is said product
    25/54 gene in Clostridium beijerinckii NRRL B593 (Toth et al. (1999) Appl. Environ. Microbiol. 65: 4973-4980, GenBank No: AAD31841).
    3) Proteins that are part of a bifunctional aldolase-dehydrogenase complex involved in the catabolism of 4-hydroxy-2-ketovalerate. Such bifunctional enzymes catalyze the final two stages of the meta-cleavage pathway for catechol, an intermediate in many bacterial species in the degradation of phenols, toluates, naphthalene, biphenis and other aromatic compounds (Powlowski and Shingler (1994) Biodegradation 5, 219-236 ). 4-hydroxy-2-ketovalerate is first converted by 4-hydroxy-2-ketovalerate aldolase to pyruvate and acetaldehyde, subsequently, acetaldehyde is converted by acetylating acetaldehyde dehydrogenase to acetyl-CoA. An example of this type of acetyldehyde acetylating dehydrogenase is the DmpF protein in Pseudomonas sp CF600 (GenBank No: CAA43226) (Shingler et al. (1992) J. Bacteriol. 174: 71 1-24). The E. coli MphF protein (Ferrandez et al. (1997) J. Bacteriol. 179: 2573-2581, GenBank No: NP_414885) is homologous to the DmpF protein in Pseudomonas sp. CF600.
    [062] A suitable nucleic acid sequence can be found, in particular, in a selected Escherichia organism, in particular E. coli; in particular Mycobacterium marinum, ulcerans, Mycobacterium tuberculosis; in particular Carboxydothermus from the Mycobacterium group, Mycobacterium
    Carboxydothermus, hydrogenoformans; Entamoeba, in particular Entamoeba histolytica; Shigella, in particular Shigella sonnei; Burkholderia, in particular Burkholderia pseudomallei,
    26/54
    Klebsiella, in particular Klebsiella pneumoniae; Azotobacter, in particular Azotobacter vinelandii; Azoarcus sp; Cupriavidus, in particular Cupriavidus taiwanensis; Pseudomonas, in particular Pseudomonas sp. CF600; Pelomaculum, in particular Pelotomaculum thermopropionicum. Preferably, the nucleic acid sequence encoding the NAD + dependent acetylating acetaldehyde dehydrogenase originates from Escherichia, more preferably from E. coli.
    [063] Particularly suitable is an E. coli mhpF gene, or a functional homologue thereof. this gene is described in Ferrandez et al. (1997) J. Bacteriol. 179: 2573-2581. Good results were obtained with S. cerevisiae, in which an E. coli mhpF gene was incorporated.
    [064] In an additional advantageous embodiment, the nucleic acid sequence encoding an acetaldehyde dehydrogenase (acetylant) is in particular Pseudomonas, dmpF from Pseudomonas sp. CF600.
    [065] In principle, the nucleic acid sequence encoding NAD + dependent acetylating acetaldehyde dehydrogenase may be a wild type nucleic acid sequence.
    [066] A preferred nucleic acid sequence encodes the NAD + -dependent acetyldehyde acetaldehyde represented by SEQ ID NO: 2, SEQ ID NO: 29, or a functional homologue of SEQ ID NO: 2 or SEQ ID NO: 29. In particular , the nucleic acid sequence comprises a sequence according to SEQ ID NO: 1. SEQ ID NO: 28 or a functional homologue of SEQ ID NO: 1 or SEQ ID NO: 28.
    [067] Additionally, an acetaldehyde sequence
    27/54 acetylating dehydrogenase (or nucleic acid sequence encoding such activity), for example, can be selected from the group of Escherichia coli adhE, Entamoeba histolytica adh2, Staphylococcus aureus adhE, Piromyces sp. AdhE, EDK33116 de Clostridium kluyveri, acdH of Lactobacillus plantarum and YP 001268189 of Pseudomonas putida. For the sequences of these enzymes, nucleic acid sequences encoding these enzymes and methodology for incorporating the nucleic acid sequence into a host cell, reference is made to WO 2009/013159, in particular example 3, table 1 (page 26) and the mentioned sequence ID numbers, whose table 1 of the publication and the sequences represented by the sequence ID numbers mentioned in said table are hereby incorporated by reference.
    [068] In general, a cell according to the invention also comprises an acetyl-Coenzyme A synthetase, whose enzyme catalyzes the formation of acetyl-coenzyme A, from acetate. This enzyme may be present in the wild-type cell, for example, as is the case for S. cerevisiae, which contains two isoenzymes acetyl-Coenzyme A synthase encoded by the genes ACSl [SEQ ID NO: 17] and ACS2 [SEQ ID NO: 18] (van den Berg et al (1996) J. Biol. Chem. 271: 28953-28959), or a host cell may be provided with one or more heterologous gene (s) encoding this activity, for example For example, the S. cerevisiae ACS1 and / or ACS2 gene or a functional homologue thereof can be incorporated into a cell that lacks the activity of acetyl-Coenzyme A isoenzyme synthetase.
    [069] In addition, particularly in view
    28/54 of an efficient ethanol production, but also in relation to an efficient oxidation of NADH, it is preferable that the cell comprises an NAD + -dependent alcohol dehydrogenase (EC 1.1.1.1). This enzyme catalyzes the conversion of acetaldehyde to ethanol. The cell can naturally comprise a gene that encodes a dehydrogenase like this, as is the case with S. cerevisiae (ADHl-S) [SEQ ID NO: 19-23], see 'Lutstorf and Megnet. 1968 Arch. Biochem. Biophys. 126: 933-944 ', or' Ciriacy, 1975, Mutat. Res. 29: 315-326 '), or a host cell can be provided with one or more heterologous gene (s) encoding this activity, for example, any of the ADH1-5 genes from S. cerevisiae or functional homologues of this can be incorporated into a cell that does not show NAD + dependent alcohol dehydrogenase activity.
    [070] The specifically preferred cells, according to the invention, are the cells of the strain of S. cerevisiae deposited on July 16, 2009 at Centraalbureau voor Schimmelcultures (Utrecht, Netherlands) with deposit number CBS125049.
    [071] In a specific aspect, the present invention is directed to a method of preparing a recombinant yeast cell according to the invention.
    [072] The genetic modification of a cell, comprising the incorporation of one or more heterologous nucleic acid sequences into a host cell, and generally comprising mutation (including complete deletion) of a gene that encodes an enzymatic activity necessary for the synthesis of NADH-dependent glycerol, can be based on common general knowledge, for example, by techniques
    29/54 patterns of molecular biology and genetics, generally known in the art and which have been previously described (for example, Maniatis et al. 1982 Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; Miller 1972 Experiments in molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor; Sambrook and Russell 2001 molecular cloning:.. a laboratory manual (3rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press; F. Ausubel et al, eds, Current protocols in molecular biology, Green Publishing and Wiley Interscience, New York 1987).
    [073] A method of invention prepares a cell of recombinant yeast in wake up with the invention comprising: (a) provide a cell in yeast, preferably a cell in yeast selected from the group yeast cells not features activity enzyme needed to The glycerol synthesis dependent
    NADH, and yeast cell with reduced enzyme activity with respect to glycerol synthesis compared to its corresponding wild type yeast cell;
    (b) obtaining a nucleic acid segment comprising a gene that is heterologous to said yeast cell and encodes an enzyme that exhibits NAD + -dependent acetyldehyde acetaldehyde activity, and wherein said gene is operably linked to a functional promoter in said yeast cell;
    (c) if wanted (for example, if the cell in yeast not to present activity of acetyl-Coenzyme THE synthase, or in which activity of acetyl-Coenzyme THE
    30/54 synthase (s) completely limits the in vivo activity of the pathway for converting acetate to ethanol, or expresses acetyl-Coenzyme synthase in a cell compartment that is not compatible with its use in the invention), obtain a nucleic acid segment comprising a gene that is heterologous to said yeast cell and encodes an enzyme that exhibits acetyl-Coenzyme A synthase activity, and wherein said gene is operably linked to a functional promoter in said yeast cell;
    (d) if desired (for example, if the yeast cell does not show NAD + dependent alcohol dehydrogenase activity, or where NAD + dependent alcohol dehydrogenase activity limits the in vivo activity of the pathway for converting acetate to ethanol, or expresses NAD + -dependent alcohol dehydrogenase in a cell compartment that is not compatible with its use in the invention), obtain a nucleic acid segment comprising a gene that is heterologous to said yeast cell and encodes an enzyme that exhibits the activity an NAD + -dependent alcohol dehydrogenase, and wherein said gene is operably linked to a functional promoter in said yeast cell; and (e) transforming a yeast cell with said segment or segments of nucleic acid, thereby providing a recombinant yeast cell that expresses said heterologous gene, and wherein said recombinant yeast cell exhibits reduced glycerol-dependent synthesis of NADH in fermentative conditions, compared to a corresponding non-recombinant yeast cell, or in which in said yeast cell the glycerol-dependent synthesis of
    31/54
    NADH in fermentative conditions is absent.
    [074] Promoters for yeast cells are known in the art and can be, for example, TPI1 triose-phosphate dehydrogenase promoters, glyceraldehyde-3-phosphate dehydrogenase TDH3 promoters, promoters of translational elongation factor EF-I alpha TEF1, ADH1 alcohol dehydrogenase promoters, glucose-6-phosphate dehydrogenase gpdA and ZWF1 promoters, protease promoters such as pepA, pepB, pepC, glaA glycoamylase promoters, amyA amylase promoters, amyB catalysts, amyase promoters or catA, glucose oxidase goxC promoter, beta-galactosidase lacA promoter, alpha-glucosidase aglA promoter, tefA translation elongation factor promoter, xylanase promoters such as xlnA, xlnB, xlnC, xlnO, cellulase promoters such such as eglA, eglB, cbhA, promoters of transcriptional regulators such as areA, creA, xlnR, pacC, prtY, etc., or any other, and can be found, among others, on the NCBI website (http: //www.ncbi .nlm.n ih.gov/entrez/).
    [075] In a preferred embodiment, the heterologous nucleic acid sequence to be introduced into a yeast cell, during the preparation of a recombinant yeast cell of the invention, is incorporated into a vector and the transformation of the cell is carried out with the vector . If more than one heterologous nucleic acid sequence (which encodes different enzyme activities or which together encode a single enzyme activity) must be incorporated, these nucleic acid sequences can be present in a single vector or these nucleic acid sequences can be incorporated as part of
    32/54 separate vectors.
    [076] In this way, the invention relates additionally to a vector for the expression of a heterologous polypeptide in a yeast cell, in particular a yeast cell, said expression vector comprising one or more heterologous sequences of operably linked nucleic acids to a functional promoter in the yeast cell, and said heterologous nucleic acid sequence (s) encoding a polypeptide with enzymatic activity to convert acetyl-Coenzyme A to acetaldehyde (the cytosol de) in said yeast cell, wherein said polypeptide preferably comprises a sequence according to SEQ ID NO: 2, or a functional homolog thereof.
    [077] The vector (used in a method) of the invention can be a phage vector, a bacterial vector, a centromeric, episomal or integrating plasmid vector, or a viral vector.
    [078] In a preferred embodiment, the vector is a vector for expression in Saccharomyces, in particular S. cerevisiae. In such a modality, the heterologous nucleic acid sequence encoding NAD + -dependent acetyldehyde acetaldehyde activity can be optimized by codon (pair) for expression in Saccharomyces, in particular S. cerevisiae, although good results have been achieved with a nucleic acid sequence encoding the wild type.
    [079] In order to achieve optimal expression in a specific cell (such as S. cerevisiae), the use of the codon (pair) of the heterologous gene can be optimized using any
    33/54 one of a variety of synthetic gene determination software packages, for example, GeneOptimizer® from Geneart AG (Regensburg, Germany) for optimizing codon usage or optimizing codon pair usage as described in PCT / EP2007 / 05594. Such adaptation of codon usage ensures that heterologous genes, which are of bacterial origin, for example, are processed efficiently by the yeast transcription and translation machinery. Optimizing the use of the codon pair will result in better protein expression in the yeast cell. The optimized sequences, for example, can be cloned into a multi-copy yeast expression plasmid, operably linked to a functional (preferably constitutive) promoter in a fungus (yeast).
    [080] In the manner indicated above, the invention additionally concerns the preparation of ethanol.
    [081] For a method of preparing ethanol, a cell according to the invention that is used in anaerobic conditions fermentes a sugar, thereby forming ethanol. Yeast cells suitable for fermenting sugar are generally known and include, among others, S. cerevisiae. In a method of the invention, a yeast cell that is used also produces an NAD + dependent acetylating acetaldehyde dehydrogenase (EC 1.2.1.10). This cell can be obtained in the manner described above and is illustrated in the example hereinafter. If used for the preparation of ethanol, the cell preferably also includes an activity of acetyl-Coenzyme A synthetase. If used for the preparation of ethanol, the cell preferably also includes an activity of
    34/54 NAD + dependent alcohol dehydrogenase. These activities can be naturally present, as in S. cerevisiae, or are provided by genetic modification (see also here earlier).
    [082] The fermentation conditions can be, in principle, based on conditions generally known, for example, in the manner described in the review by Van Maris cited above, or the references cited in this, stipulating that, typically, the medium is not the fermentation is carried out comprises acetate in addition to the fermentable carbohydrate (s).
    [083] The molar ratio of acetate to carbohydrate consumed by anaerobic cultures of yeast cells, modified according to the invention, is generally at least 0.004, in particular at least 0.01, at least 0.03, at least 0, 1, or at least 0.2. The acetate to carbohydrate molar ratio present in lignocellulosic biomass hydrolysates is generally less than 0.70, in particular 0.5 or less, more in particular 0.3 or less, or 0.2 or less. Here, the number of moles of carbohydrate is based on monosaccharide units, that is, one mole of an oligo / polysaccharide with n counts of monosaccharide units such as n mol.
    [084] In absolute terms, the concentration of fermentable carbohydrate is generally in the range of 65 to 400 g / L, in particular in the range of 100 to 250 g / L.
    [085] In absolute terms, the acetate concentration is generally in the range of 0.5 to 20 g / L, in particular in the range of 1-15 g / L, more particularly in the range of 2 to 12 g / L .
    35/54 [086] The pH can be chosen depending on how acceptable it is by the organism that is used, based on common general knowledge, or it can be determined routinely. In general, fermentation is carried out at a neutral or acidic pH, in particular at a pH in the range of 2-7, more in particular at a pH of 3-6, even more in particular 3.5-5.5 (pH apparent, as measured in the fermentation medium at the temperature at which fermentation occurs).
    [087] The temperature can be chosen depending on how acceptable it is for the organism that is used. In general, the temperature is in the range of 15-50 degrees C, in particular in the range of 25-45 degrees C.
    [088] As a fermentable carbohydrate, in principle, any carbohydrate that can be used is metabolized by the specific recombinant cell, with ethanol as a metabolic product. The cell may naturally comprise the required metabolic enzyme system, or the cell may have been genetically modified for this purpose, for example, in the manner described by the review by Van Maris, the references cited therein, or in the manner described in the present disclosure. Preferably, the fermentable carbohydrates in the hydrolyzate comprise at least one carbohydrate selected from the group of hexoses, pentoses and oligosaccharides that comprise one or more units of hexose and / or pentose. In particular, if the recombinant cell is from the Saccharomyces group, preferably S. cerevisiae, at least one carbohydrate selected from glucose, fructose, sucrose, maltose, galactose, xylose, arabinose and mannose is used. Good results were obtained with glucose.
    36/54 [089] A method according to the invention is suitable, in particular, for preparing ethanol using a hydrolyzate of at least one polymer selected from cellulose, hemicellulose and pectin, preferably at least one polymer selected from hemicellulose and pectin, in due to the hydrolysis of these polymers, the acetate is typically released by hydrolysis or formed as a decomposition product. In particular, the hydrolyzate can be hydrolyzed lignocellulosic material, such as lignocellulosic biomass. For example, lignocellulosic material can be selected from agricultural lignocellulosic material, for example, cotton, straw, elephant grass, bagasse, corn straw, aquatic plant lignocellulosic material, beet pulp, citrus fruit peels, lignocellulosic materials from forest such as lignocellulosic waste material from trees or shrubs (trimmed / pruned / cut plant material, sawdust, etc.) or trees or shrubs grown specifically as a source for lignocellulosic materials, for example, poplar trees, cellulosic (ligneous) waste industry, for example, wood pulp, waste paper.
    [090] Preferably, a lignocellulosic hydrolyzate comprises one or more fermentable sugars (particularly glucose, xylose and arabinose) and acetate, which were formed during hydrolysis. Thus, in a preferred embodiment of the invention, the ethanol preparation comprises a step in which a lignocellulosic material is hydrolyzed, thereby forming a hydrolyzate comprising one or more fermentable carbohydrates, in
    37/54 particular glucose, and optionally one or more other hexoses and pentoses and acetate, the hydrolyzate of which is thereafter placed in contact with a recombinant cell of the invention. The relative concentrations of acetate and fermentable carbohydrates, in the substrate that is put in contact with the recombinant cell of the invention, can be modified to optimize the conditions for hydrolysis, mixing different hydrolysates and / or mixing (partially) with refined carbohydrate sources and / or acetic acid.
    [091] The appropriate hydrolysis methodology can be based on the Van Maris review mentioned above, or his references cited, and includes enzymatic hydrolysis, thermal hydrolysis, chemical hydrolysis and combinations of these. Polymers that are hydrolyzed in general to the extent of at least 50%, preferably at least 90%, in particular at least 95% of the chains, are degraded into monosaccharide units or monosaccharide units and disaccharide units.
    [092] The invention is now illustrated by the following examples:
    EXAMPLES
    EXAMPLE 1
    Materials and methods
    Construction and maintenance of the strain [093] The Saccharomyces cerevisiae strains used (table 1) originate from the CEN.PK family, which was previously identified as an adequate basis for combined genetic and physiological studies (van Dijken et al. (2000) Enzyme Microb. Technol. 26: 706-714).
    38/54
    Table 1. Used Saccharomyces cerevisiae strains
    39/54
    Strain Relevant genotype Source / reference CEN.PK113-5D MATa ura3 GPD1 GPD2 Collection strainEUROSCARF,Frankfurt,Germany IME076 MATa ura3 GPD1 GPD2 (Reference) p426 GPD (URA3) CEN.PK102-3A MATa ura3 leu2 GPD1 GPD2 Collection strainEUROSCARF,Frankfurt,Germany RWB0094 MATa ura3 leu2 gpd1 (- BIRD 1.1133) :: loxP-KanMX-loxP Engineering, gpd2 (-2,1281) :: hphMX4 Rotterdam IMZ008 MATa ura3 leu2 gpd1 (-1.1133) :: loxP gpd2 (-2.1281) :: hphMX4YEplac181 (LEU2) IMZ132 MATa ura3 leu2 gpd1 (- Deposited in (CBS125049) 1.1133) :: loxP gpd2 (- Centraalbureau 2.1281) :: hphMX4 voor YEplac181 (LEU2) Schimmelcultures pUDE43 (URA3 pTHD3 :: mhpF on July 16th (E.coli) :: CYC1t) 2009. IMZ127 MATa ura3 leu2 gpd1 (-1.1133) :: loxP gpd2A (-2.1281) :: hphMX4YEplac181 (LEU2)p426 GPD (URA3)
    [094] To disrupt the GPD1 gene (YDL022W), the
    40/54 loxP-KanMX-loxP interruption cassette can be amplified by PCR, according to Güldener et al. (1996, Nucleic Acids Res. 24: 2519-2524), using a set of primer oligonucleotides containing flanking regions of nucleotide 45 homologous to the sequences in the GPD1 gene, and approximately nucleotide 20 homologous to the sequences of the pUG6 interruption module (Gúldener et (1996) Nucleic Acids Res. 24: 2519-2524) (Figure 2, Table 2). Similarly, plasmid pAG32 ((Goldstein and McCusker (1999) Yeast 15: 1541-1553) can be used as a template for PCR amplification of the hphMX4 interrupt module. For the construction of a GPD2 interrupt cassette (YOL059W), a set of primer oligonucleotides can be used, containing flanking regions of nucleotide 45 homologous to the sequences in the GPD2 gene and sequences of 20 nucleic acids homologous to the sequences of the pAG32 interrupter module (table 2).
    Table 2. Oligonucleotides for the inactivation of the GPD1 and GPD2 genes and for the verification of correct interruption by diagnostic PCR. The gene interruption oligonucleotides, nucleotides homologous to the sequences both to the left (5 'side) and to the right (3' side) of the genes to be deleted are indicated in capital letters; lowercase letters indicate nucleotides homologous to the sequence of the interrupt cassettes.
    Genetarget GPD1 / YDL022W GPD2 / YOL059W Oligonuc fw fw leotid 5'TTGTACACCCCCCCCCTCCAC 5'TCAATTCTCTTTCCCTTTCCTTTT s AAACACAAATATTGATAATATAA CCTTCGCTCCCCTTCCTTATC
    41/54
    initiated Acagctgaagcttcgtacgc ccaggctgaagcttcgtacg res of [SEQ ID NO: 5] [SEQ ID NO: 7] interrup tion of rv rv gene 5'AATCTAATCTTCATGTAGATC 5'GTGTCTATTCGTCATCGATGTCTA TAATTCTTCAATCATGTCCGGCG GCTCTTCAATCATCTCCGGTAGgcat gcataggccactagtggatctg aggccactagtggatc [SEQ ID NO: 6] [SEQ ID NO: 8] Oligonuc leotid fw 5 'GPD1 s 5 'CCCACCCACACCACCAATAC fw 5 'GPD2 initiated [SEQ ID NO: 9] 5 'GTTCAGCAGCTCTTCTCTAC res of [SEQ ID NO: 11] Checks rv 3 'GPD1 dog - 5 'CGGACGCCAGATGCTAGAAG rv 3 'GPD2 gene 5 'CCAAATGCGACATGAGTCAC [SEQ ID NO: 10] target [SEQ ID NO: 12] specific co Oligonuc leotid fw KANB Fw KANB s 5 'CGCACGTCAAGACTGTCAAG 5 'CGCACGTCAAGACTGTCAAG initiated [SEQ ID NO: 13] [SEQ ID NO: 15] res of Checks rv KANA rv KANA dog - 5 'TCGTATGTGAATGCTGGTCG 5 'TCGTATGTGAATGCTGGTCG cassette [SEQ ID NO: 14] [SEQ ID NO: 16] in interrup
    42/54
    dogspecificco
    [095] The transformation of the interrupting cassettes GPD1 and GPD2 amplified by PCR into the strain Saccharomyces cerevisiae CEN.PK102-3A (Table 1) can be performed according to the protocols described by Guldener et al (Nucleic Acids Res. (1996) 24 : 2519-2524), followed by selection of transformants in the complex YPD medium (Burke et al. (2000) Methods in yeast genetics. Cold Spring Harbor Press Plainview, NY) with 200 mg / L of G-418 for strains transformed with the KanMX suspension cassette and 300 mg / L of hygromycin B for strains transformed with the hphMX4 suspension cassette. Confirmation of correct integration of the GPD1 gene interruption cassette can be verified by colony PCR, using combinations of 5 'GPD1 KANA and 3' GPD1 KANB primer oligonucleotides (Table 2). The correct inactivation of GPD2 can be verified similarly with the set of 5 'GPD2 KANA and 3' GPD2 KANB primer oligonucleotides (Table 2). The RWB0094 strain, which carries deletions in the open reading frames of the GPD1 and GPD2 genes of the CEN.PK102-3A (MATa ura3 Ieu2) which were replaced by the loxP-KanMXloxP cassette and the hphMX4 cassette, respectively, was purchased from BIRD Engineering, Rotterdam, Netherlands. The KanMX marker of strain RWB0094 was removed by the expression of Cre recombinase (Guldener et al (1996) Nucleic Acids Res. 24: 2519-2524) and its auxotrophy to leucine was complemented by transformation with the plasmid YEPlac181 that carries LEU2 (Gietz, RD and S. Akio. (1988) Gene 74: 527-534.), yielding
    43/54 the IMZ008 strain. Figure 1 2 shows schematically the gene interruption procedure, the replacement of GPD1 ORF by KanMX and GPD2 ORF by hphMX4. Arrows indicate the oligonucleotide primers for PCR verification of diagnosis of correct gene inactivation.
    [096] Transformation of the IMZ008 strain with the mHpF expression plasmid pUDE43 that carries URA3 (see below) yielded the prototrophic IMZ132 strain that carries mhpF, transformation with the empty p426_GPD vector that carries URA3 yielded the IMZ127 strain. Finally, the transformation of the CEN.PK113-5D (ura3) strain with p426_GPD yielded the prototrophic GPD1 GPD2 reference strain IME076. Cultures transformed with the deletion cassettes were plated in a complex YPD medium containing G418 (200 mg L -1 ) or hygromycin (200 mg L -1 ). The satisfactory integration of the deletion cassettes was confirmed by diagnostic PCR. The stock cultures of all strains were grown in shake flasks containing 100 mL of synthetic medium (see below), with 20 g L -1 of glucose as a carbon source. After adding 30% (v / v) glycerol, 1 ml aliquots of cultures in stationary phase were stored at -80 ° C.
    Plasmid construction [097] The E. coli mhpF gene (EMBL accession number Y09555.7) was amplified by PCR from the genomic DNA of the E. coli K12 strain JM109, using the mhpF-sense oligonucleotide pairs ( 5'GGGGACAAGTTTGTACAAAAAAGCAGGCTATGAGTAAGCGTAAAGTCGCCATTATCGG-3 '[SEQ ID NO: 3]) and mhpF-reverse (5'GGGGACCACTTTGTACAAGAAAGCTGGGTGTTCATGGGGTGTTCGCCGCT
    44/54 [SEQ ID NO: 4]), which contained the attBl and attB2 sequences, respectively. The polymerase chain reaction (PCR) was performed using Phusion® Hot Start high-fidelity DNA polymerase (Finnzymes Oy, Espoo, Finland), according to the manufacturer's specifications and on a Biometra TGradient thermal cycler (Biometra, Gottingen, Germany) with the following adjustments: 25 cycles of 10 seconds, denaturation at 98 ° C, and 30 seconds of annealing and extension at 72 ° C. The 1011 bp PCR product was cloned using Gateway® cloning technology (Invitrogen, Carlsbad, CA, USA). Plasmid pDONR221, using the BP reaction, was used to create the input clone, determined as plasmid pUD64. From this entry clone and the multi-copy plasmid pAG426GPD-ccdB (Addgene, Cambridge, MA, USA), the yeast pUDE43 expression plasmid was constructed using the LR reaction. The transformations of the products of the recombination reaction into the competent E. coli K12 JM109 strain were performed according to the E. coli Z-Competent ™ transformation kit (Zymoresearch Corporation, Orange, USA), and plated in LB medium containing both ampicillin (100 mg L -1 ) and kanamycin (50 mg.L -1 ). Yeast transformations were performed according to Burke et al. (Methods in yeast genetics (2000.) Cold Spring Harbor Laboratory Press Plainview, NY.) After transformations with the yeast expression plasmid, cells were plated in synthetic media. The satisfactory insertion of the multicopy plasmid pUDE43 was confirmed by diagnostic PCR using the primer pairs for cloning.
    45/54
    Cultivation and media [098] Cultivation in a shaking flask was carried out at 30 ° C in a synthetic medium (46). The pH of the medium was adjusted to 6.0 with 2 M KOH before sterilization.
    [099] Pre-cultures were prepared by inoculating 100 mL of medium containing 20 g L -1 of glucose in a 500 mL shake flask with frozen (1 mL) stock culture. After 24 hours of incubation at 30 ° C in an incubator with an Innova® shaker (200 rpm, New Brunswick Scientific, NJ,
    USA), cultures were transferred to the bioreactors. Fermentations under anaerobic conditions were carried out at 30 ° C in 2-liter laboratory bioreactors (Applikon, Schiedam, Netherlands) with a functional volume of 1 liter. The synthetic medium with 20 g I- 1 of glucose (46) was used for all fermentations and was supplemented with 100 pL L -1 of silicone defoamer (Silcolapse 5020, Caldic Belgium, Bleustar Silicones), as well as anaerobic growth factors, ergosterol (0.01 g L -1 ) and Tween 80 (0.42 g L -1 ) dissolved in ethanol. This resulted in 11-13 mM ethanol in the medium. Where indicated, acetic acid was added at a concentration of 2 g L -1 and the pH was readjusted to 5.0 before inoculation. The pH of the culture was maintained at 5.0 by the automatic addition of 2M KOH. The cultures were shaken at 800 rpm and dispersed with 0.5 L min -1 of nitrogen (<10 ppm of oxygen). Dissolved oxygen was monitored with an autoclavable oxygen electrode (Applisens, Schiedam, Netherlands). To minimize the diffusion of oxygen, the bioreactors were equipped with Norprene tubes (Cole Palmer Instrument Company, Vernon Hills, USA). All fermentations were carried out at least in duplicate.
    46/54
    Determination of dry weight and optical density of the culture [100] The culture samples (10 mL) at selected interval times were filtered with pre-weighed nitrocellulose filters (0.45 pm pore size; Gelman Laboratory, Ann Arbor, USA ). After removing the medium, the filters were washed with demineralized water and dried in a microwave oven (Bosch, Stuttgart, Germany) for 20 minutes at 350 W and weighed. Duplicate determinations varied by less than 1%. The growth of the culture was also monitored by means of optical density readings at a wavelength of 660 nm in a spectrophotometer ®
    Novaspec II.
    Gas analysis [101] The exhaust gas was cooled in a condenser (2 ° C) and dried with a Permapure type MD-11048P-4 dryer (Permapure, Toms River, USA). The concentrations of oxygen and carbon dioxide were determined with an NGA 2000 analyzer (Rosemount Analytical, Orrville, USA). The exhaust gas flow and carbon dioxide production rates were determined in the manner previously described (3). In calculating these specific biomass rates, a correction was made for volume changes caused by the removal of culture samples.
    Metabolite analysis [102] The supernatant obtained by centrifugation of culture samples was analyzed for glucose, acetic acid, succinic acid, lactic acid, glycerol and ethanol, using HPLC analysis on a Waters Alliance 2690 HPLC device (Waters , Milford, USA) containing a Biorad HPX 87H column (Biorad, Hercules, USA). The column was
    47/54 eluted at 60 ° C with 0.5 g L -1 of H 2 SO 4 in a flow rate of 0.6 mL min -1 . The detection was by means of a Waters 2410 refractive index detector and a Waters 2487 UV detector. The determined glycerol determination concentrations were a kit from AG, Darmstadt, initial and final plus additionally using enzymatic (R-Biopharm
    Germany). During cultivation in bioreactors that are dispersed with nitrogen gas, a significant fraction of ethanol is lost through the exhaust gas. To correct this, the ethanol evaporation kinetics was analyzed in bioreactors operated under identical conditions, in different volumes of operation with sterile synthetic medium. The ethanol evaporation constants dependent on the resulting volume (for this, a setting equal to 0.0080 divided by the volume in liters, expressed in h -1 ) were used to correct the HPLC measurements of ethanol concentrations in the culture supernatants, taking take into account changes in volume that were caused by sampling.
    Enzyme activity assays [103] Cell extracts for NAD + -dependent acetaldehyde dehydrogenase (acetylating) activity assays were prepared from exponentially growing cultures under anaerobic conditions, as previously described (Abbott et al., Appl. Environ, Microbiol. 75: 23202325). The activity of acetaldehyde dehydrogenase (acetylant) dependent on NAD + was measured at 30 ° C monitoring the oxidation of NADH at 340 nm. The reaction mixture (total volume 1 ml) contained 50 mM potassium phosphate buffer (pH 7.5), 15 mM NADH and cell extract. THE
    48/54 reaction started by adding 0.5 mM acetyl-Coenzyme. For the determination of glycerol 3-phosphate dehydrogenase activity (EC 1.1.1.8), cell extracts were prepared in the manner described above, with the exception that the phosphate buffer was replaced by the triethanolamine buffer (10 mM, pH 5) (5 , 19). Glycerol-3-phosphate dehydrogenase activities were assayed in cell extracts at 30 ° C, in the manner previously described (Blomberg and Adler (1989), J. Bacteriol. 171: 1087-1092. The reaction rates were proportional to the amounts of added cell extract Protein concentrations were determined by the Lowry method (Lowry et al (1951) J. Biol. Chem. 193: 265-275) using bovine serum albumin as a standard.
    Results
    Growth and product formation in anaerobic batch cultures [104] When cultures of the S. cerevisiae IME076 prototrophic strain (GPD1 GPD2) were supplemented with 2.0 g L -1 of acetic acid, the specific growth rate (0, 32 h -1 ) was identical to that reported for the growth of cultures in the absence of acetic acid (0.34 h -1 ), Kuyper et al. (2005) FEMS Yeast Res. 5: 399-409. The addition of acetic acid led to a small decrease in the biomass yield and, consequently, a decrease in the glycerol yield in glucose compared to cultures grown in the absence of acetic acid (Figure 2, Table 3).
    [105] This effect was attributed to the higher glucose dissimilation rate for pH homeostasis
    49/54 intracellular, due to the diffusion of acetic acid in the cell, which in turn results in a lower yield of glucose biomass. Under the same conditions, an isogenic gpd1A gpd2A strain, in which the absence of NAD + -dependent glycerol-3-phosphate dehydrogenase activity was confirmed in cell extracts (Table 2), was completely unable to grow anaerobically (Figure 2), consistent with notion that the production of glycerol by means of Gpd1 and Gpd2 is essential for the reoxidation of NADH in anaerobic cultures of S. cerevisiae.
    Table 3. Physiology of the genetically modified strain of S. cerevisiae IMZ132 and the empty vector reference strain IME076, during anaerobic cultivation in batches in synthetic medium (pH 5) with glucose-acetate mixtures.
    50/54
    Yeast strain IME076 IMZ132 Relevant genotype GPD1 GPD2 gpdlA gpd2A+ mhpF Glycerol 3-phosphate dehydrogenase (pmol mg 0.034 ± 0.003 <0.002 protein -1 min -1 ) Acetaldehyde dehydrogenase (acetylating) <0.002 0.020 ± 0.004 (pmol mg protein -1 min -1 ) Specific growth rate (h -1 ) 0.32 ± 0.01 0.14 ± 0.01 Yield of glucose biomass (gg -1 ) in 0.083 ± 0.000 0.082 ± 0.009 Yield of biomass acetate (gg -1 ) in at , 3.8 ± 0.5 Yield of glycerol glucose (gg -1 ) in 0.073 ± 0.007 <0.002 Ethanol yield in glucose (gg -1 ) uncorrelated evaporation with 0.39 ± 0.01 0.43 ± 0.01 Ethanol yield in glucose (gg -1 ) correlated evaporation with 0.41 ± 0.01 0.47 ± 0.01
    n.a., not applicable.
    [106] The expression of the E. coli mhpF gene in a gpdlA gpd2A strain, resulting in acetyl-CoA-dependent rates of NADH reduction in cell extracts of 0.020 pmol min 1 (mg of protein) -1 (Table 3), did not make it possible
    51/54 anaerobic growth when glucose was the only carbon source. However, when the medium was supplemented with 2.0 g L -1 of acetic acid, exponential growth was observed at a specific growth rate of 0.14 h 1 . No glycerol formation occurred during cultivation. (Figure 2, Table 3). The trace amounts (<1 mM) of glycerol present in cultures of the gpd1A gpd2A strains originate from the inoculum of cultures that started from the frozen glycerol stocks. Ethanol was the main organic product and the small amounts of succinate and lactate produced were similar to those observed in cultures of the reference strain grown under the same conditions (data not shown).
    [107] It is observed that the fermentations of IMZ 132 (40 hours) took longer than those of the wild type strain (15 h) and the anaerobic cultures in batches were dispersed with nitrogen gas. Thus, the fraction of ethanol lost through evaporation was greater for the IMZ 132 strain. After determining the ethanol evaporation kinetics in sterile control experiments and correcting ethanol yields, an apparently higher 13% ethanol yield in glucose was shown for the genetically modified strain according to the invention, using the linear path for NADH-dependent reduction of acetic acid in ethanol (Table 3).
    Discussion [108] The present study provides proof of the principle that, stoichiometrically, the role of glycerol as a dissipation of redox potential in growth
    52/54 anaerobic S. cerevisiae can be completely replaced by a linear path for NADH-dependent reduction of acetate in ethanol. This offers interesting prospects for the large-scale production of ethanol from raw materials that contain acetic acid, such as lignocellulosic hydrolysates.
    [109] In addition to reducing the organic carbon content of exhausted media and increasing ethanol yield, the reduction of acetic acid in ethanol can at least partially facilitate the inhibition of acetate in yeast growth and metabolism, which is especially problematic in low pH, and during the consumption of pentose sugars by genetically modified yeast strains.
    EXAMPLE 2:
    [110] This example concerns the fermentative production of glycerol-free ethanol by a Saccharomyces gpd1A gpd2A strain. cerevisiae, which expresses an optimized version of the codon (SEQ ID NO: 28) of the wild type dmpF gene of Pseudomonas sp. CF600 (GenBank No: CAA43226) (Shingler et al. (1992) J. Bacteriol. 174: 71 1-24).
    [111] For this purpose, the same procedures and techniques used for the construction and performance evaluation of the IMZ132 strain (gpd1Agpd2A mhpF) were used. These procedures and techniques are described in the materials and methods section of example 1. In this work, the transformation of the IMZ008 strain (gpd1Agpd2Aura3A) with the expression plasmid pUDE47 dmpf that carries URA3 yielded the prototrophic strain IMZ130 that expresses dmpF. For the construction of plasmid pUDE47, an optimized copy of the
    53/54 codon of the dmpF gene (EMBL accession number X60835.1) from Pseudomonas sp. CF600 was ligated into plasmid p426_GPD. Codon optimization for expression in S. cerevisiae and ligation on plasmid p426_GPD were performed by BaseClear BV (Leiden, Netherlands). The satisfactory insertion of the multicopy pUDE47 plasmid was confirmed using the colony PCR diagnosis, which uses the dmpF-sense (CATTGATTGCGCCATACG) and dmpF-reverse (CCGGTAATATCGGAACAGAC) primer pairs.
    Results
    Growth and product formation in anaerobic batch cultures [112] The expression of the dmpF gene from Pseudomonas sp. CF6 00 in a gpd1A gpd2A strain of S. cerevisiae provided results similar to those obtained for the expression of the E. coli mhpF gene in the same strain. In batch anaerobic fermentations, similar to the IMZ132 strain (gpd1A gpd2A mhpF), the functional expression of the dmpF gene together with supplementation of the medium with 2.0 g L -1 of acetic acid, resulted in exponential growth with a specific growth rate 0.11 h -1 (Figure 1). The IMZ130 strain (gpd1A gpd2A dmpF) showed a slightly longer series processing time (55 h) than the IMZ132 strain (40 h). During cultivation, the initial concentration of 20 g L -1 of glucose was completely consumed, while no glycerol formation was observed. At the same time, acetate was consumed from the initial concentration of 2.1 g L -1 to the final concentration of 1.6 g L -1 . Ethanol was the main organic product, showing an ethanol yield in
    54/54 glucose of 0.48 gg -1 (yield corrected by evaporation of ethanol). Small amounts of succinate and lactate were produced, similar to those observed in cultures of the reference strain grown under the same conditions.
    Figure 3 shows the volumetric percentage of CO 2 present in the flow of a batch fermentation inoculated with the IMZ130 strain (gpd1A gpd2A dmpF). The graph is presented on a logarithmic scale on the y axis, in order to demonstrate exponential growth and calculate the maximum specific growth rate.
    [113] The insertion of an optimized copy of the synthetic codon of the dmpF gene of Pseudomonas sp. CF600 provides another example that is stoichiometrically possible to replace the formation of glycerol as a dissipation of the redox potential in the anaerobic growth of S. cerevisiae, by a linear metabolic pathway for the NADH-dependent reduction of acetate in ethanol. Likewise, this example shows that the insertion of acetaldehyde dehydrogenase (acetylant) in a gpd1A gpd2A strain of S. cerevisiae resulted in higher ethanol-glucose yields, no formation of glycerol by-products, and consumption of the fermentation-inhibiting acetate compound.
    1/2
    权利要求:
    Claims (8)
    [1]
    1. Transgenic yeast cells, characterized by the fact that they comprise one or more heterologous recombinant nucleic acid sequences that encode a protein that has NAD + dependent acetylating acetaldehyde dehydrogenase activity (EC 1.2.1.10), in which the said cells do not have enzyme activity required for NADH-dependent glycerol synthesis, or said cells have reduced enzyme activity compared to NADH-dependent glycerol synthesis compared to a corresponding wild-type yeast cell, and in which said cells are free of NAD-dependent glycerol 3 phosphate dehydrogenase or have reduced NAD-dependent glycerol 3 phosphate dehydrogenase activity compared to the corresponding wild-type cells, and / or in which cells are free of glycerol phosphate phosphatase activity or have reduced glycerol phosphate phosphatase activity compared to the cells corresponding wild-type cells, and which comprise a genomic mutation in at least one gene selected from the group consisting of GPD1, GPD2, GPP1 and GPP2, and wherein said cells further comprise one or more nucleic acid sequences encoding an acetyl activity -coenzyme synthetase (EC 6.2.1.1) and one or more nucleic acid sequences encoding NAD + -dependent alcoholic dehydrogenase activity (EC 1.1.1.1), and
    7/10
    [2]
    2/2 in which said cells are from the Saccharomyces cerevisiae strain.
    2. Cells according to claim 1, characterized by the fact that the cells are free of genes encoding NAD + -dependent 3-phosphate glycerol dehydrogenases (EC 1.1.1.8).
    [3]
    3. Method for preparing ethanol from acetate and a fermentable carbohydrate, characterized in that it comprises growing the yeast cells as defined in claim 1 under anaerobic conditions.
    [4]
    4. Method according to claim 3, characterized by the fact that said cultivation is carried out in a fermentative medium comprising acetate and carbohydrate in a molar fraction of 0.7 or less.
    [5]
    5. Method according to claim 4, characterized by the fact that at least part of the carbohydrate and at least part of the acetate was obtained by hydrolysis of a polysaccharide selected from the group of lignocelluloses, celluloses, hemicelluloses, and pectins.
    [6]
    6. Method according to claim 5, characterized by the fact that the lignocellulosic biomass was hydrolyzed in order to obtain the fermentable carbohydrate and acetate.
    [7]
    Cells according to claim 1, characterized by the fact that at least one of said mutation is a complete deletion of said gene compared to the corresponding wild-type yeast gene.
    [8]
    8/10
    1/4
    Flank GDP1 5 ’Flank GDP1 3
    3 ’GPD1 ΚΑΝΑ
    2/4 glucose; ethanol (g Γ Ί ) OD 660 glucose; ethanol (g I); OD 660
    类似技术:
    公开号 | 公开日 | 专利标题
    US11174489B2|2021-11-16|Fermentative glycerol-free ethanol production
    US20210310013A1|2021-10-07|Acetate consuming yeast cell
    EP3359655B1|2019-11-20|Eukaryotic cell with increased production of fermentation product
    US8748140B2|2014-06-10|Xylose-fermenting microorganism
    WO2018172328A1|2018-09-27|Improved glycerol free ethanol production
    WO2019063544A1|2019-04-04|Acetic acid consuming strain
    同族专利:
    公开号 | 公开日
    ZA201200703B|2012-10-31|
    US20210230613A1|2021-07-29|
    PL2456851T3|2019-04-30|
    EA201270187A1|2012-09-28|
    US11214810B2|2022-01-04|
    ES2706653T3|2019-03-29|
    EP3828261A1|2021-06-02|
    EP2277989A1|2011-01-26|
    US20200299704A1|2020-09-24|
    US9528117B2|2016-12-27|
    EP3476931A1|2019-05-01|
    US11174489B2|2021-11-16|
    US20200248194A1|2020-08-06|
    US10738317B2|2020-08-11|
    BR112012001642A2|2015-06-16|
    CA2768897C|2019-06-11|
    JP2013500006A|2013-01-07|
    UA107467C2|2015-01-12|
    AU2010275085A1|2012-02-23|
    CN102712895B|2018-08-10|
    EP2456851A1|2012-05-30|
    US20210230614A1|2021-07-29|
    WO2011010923A1|2011-01-27|
    CN102712895A|2012-10-03|
    JP5836271B2|2015-12-24|
    US20140295514A1|2014-10-02|
    US10883110B2|2021-01-05|
    US20110275130A1|2011-11-10|
    US20190264217A1|2019-08-29|
    DK2456851T3|2019-02-11|
    US10533181B2|2020-01-14|
    CA2768897A1|2011-01-27|
    MX2012001062A|2012-03-26|
    US20160312246A1|2016-10-27|
    US8795998B2|2014-08-05|
    US20190127745A1|2019-05-02|
    EP2456851B1|2018-10-17|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US7041814B1|1998-02-18|2006-05-09|Genome Therapeutics Corporation|Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics|
    US6562958B1|1998-06-09|2003-05-13|Genome Therapeutics Corporation|Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics|
    EP1097217A2|1998-07-10|2001-05-09|Jens Nielsen|Metabolically engineered microbial cell comprising a modified redox activity|
    US7026463B2|1999-08-13|2006-04-11|Matthew Glenn|Polynucleotides and polypeptides, materials incorporating them and methods for using them|
    FR2807446B1|2000-04-11|2005-05-06|Agronomique Inst Nat Rech|GENES OF LACTOCOCCUS LACTIS, POLYPEPTIDES AND USES|
    EP1355931A2|2000-10-06|2003-10-29|Novozymes Biotech, Inc.|Methods for monitoring multiple gene expression|
    US6476209B1|2000-11-28|2002-11-05|Genesis Research & Development Corporation Ltd.|Polynucleotides, materials incorporating them, and methods for using them|
    WO2002094867A2|2001-02-07|2002-11-28|Institut Pasteur|Sequence of the photorhabdus luminescens strain tt01 genome and uses|
    SE0200857D0|2002-03-19|2002-03-19|Forskarpatent I Syd Ab|Metabolic engineering for improved xylose utilization of Saccharomyces cerevisiae|
    US7253001B2|2002-03-19|2007-08-07|Forskarpatent I Syd Ab|Metabolic engineering for improved xylose utilisation of Saccharomyces cerevisiae|
    JP4372408B2|2002-11-14|2009-11-25|三菱レイヨン株式会社|Rhodococcus genus bacterial recombinant and method for producing optically active substance using the same|
    GB0227435D0|2002-11-25|2002-12-31|Univ Denmark Tech Dtu|Metabolically engineered micro-organisms having reduced production of undesired metobolic products|
    WO2004085627A1|2003-03-26|2004-10-07|Forskarpatent I Syd Ab|New saccharomyces cerevisiae strains utilizing xylose|
    DK1781772T3|2004-07-16|2017-01-09|Dsm Ip Assets Bv|Metabolic MODIFICATION of xylose-fermenting eukaryotic cells|
    EP1858920B1|2005-02-18|2016-02-03|GlaxoSmithKline Biologicals SA|Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli|
    BRPI0614990A2|2005-08-19|2011-04-26|Univ California|genetically modified host cells and their use to produce isoprenoid compounds|
    JP5276986B2|2005-10-26|2013-08-28|ビュータマックス・アドバンスド・バイオフューエルズ・エルエルシー|Fermentative production of four-carbon alcohol|
    US20080293101A1|2006-07-27|2008-11-27|Peters Matthew W|Engineered microorganisms for increasing product yield in biotransformations, related methods and systems|
    WO2008052991A2|2006-10-31|2008-05-08|Dsm Ip Assets B.V.|Butanol production in a eukaryotic cell|
    BRPI0813710B1|2007-07-23|2018-10-09|Dsm Ip Assets Bv|A method of identifying a heterologous polypeptide having enzymatic activity to convert pyruvate, acetaldehyde or acetate to acetyl-coa in the yeast cell cytosol, vector for the expression of heterologous polypeptides in yeast, recombinant yeast cell and method of producing a fermentation product.|
    EP2060632A1|2007-10-29|2009-05-20|Technische Universität Berlin|Method of modifying a yeast cell for the production of ethanol|
    SG186645A1|2007-12-13|2013-01-30|Glycos Biotechnologies Inc|Microbial conversion of oils and fatty acids to high-value chemicals|
    DE102008004253B4|2008-01-14|2011-07-28|Butalco Gmbh|Increased production of acetyl coenzyme A|
    EP2255004B1|2008-02-20|2014-04-30|Nagarjuna Fertilizers And Chemicals Limited|Genetically transformed microorganism for biomass fermentation|
    PL2262901T3|2008-03-05|2019-04-30|Genomatica Inc|Primary alcohol producing organisms|
    EP2277989A1|2009-07-24|2011-01-26|Technische Universiteit Delft|Fermentative glycerol-free ethanol production|US5116682A|1990-12-17|1992-05-26|Bridgestone/Firestone, Inc.|Process for producing anti-wicking polyester yarn and product produced thereby|
    EP2277989A1|2009-07-24|2011-01-26|Technische Universiteit Delft|Fermentative glycerol-free ethanol production|
    WO2011140386A2|2010-05-05|2011-11-10|Mascoma Corporation|Detoxification of biomass derived acetate via metabolic conversion to ethanol, acetone, isopropanol, or ethyl acetate|
    WO2011149353A1|2010-05-27|2011-12-01|C5 Yeast Company B.V.|Yeast strains engineered to produce ethanol from acetic acid and glycerol|
    EP2576762A4|2010-06-03|2013-12-04|Mascoma Corp|Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose|
    WO2012138942A1|2011-04-05|2012-10-11|Mascoma Corporation|Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors|
    CN104024419A|2011-10-24|2014-09-03|丰田自动车株式会社|Method for producing ethanol that uses recombinant yeast|
    KR102021914B1|2011-11-09|2019-09-17|아미리스 인코퍼레이티드|Production of acetyl-coenzyme a derived isoprenoids|
    CA2857498A1|2011-11-30|2013-09-26|Mascoma Corporation|Engineering an increase in ethanol production by altering cofactor specificity|
    CA2857247C|2011-11-30|2019-07-23|Dsm Ip Assets B.V.|Yeast strains engineered to produce ethanol from acetic acid and glycerol|
    WO2014033019A1|2012-08-28|2014-03-06|Dsm Ip Assets B.V.|Yeast strains engineered to produce ethanol from acetate|
    WO2014033018A1|2012-08-28|2014-03-06|Dsm Ip Assets B.V.|Yeast strains engineered to produce ethanol from acetate|
    CN104797708A|2012-08-29|2015-07-22|拉勒曼德匈牙利流动性管理有限责任公司|Expression of enzymes in yeast for lignocellulose derived oligomer CBP|
    EP2917343A2|2012-11-09|2015-09-16|Lallemand Hungary Liquidity Management LLC|Method for acetate consumption during ethanolic fermentation of cellulosic feedstocks|
    MX2015010875A|2013-02-22|2016-06-02|Univ Delft Tech|Recombinant micro-organism for use in method with increased product yield.|
    US20160002674A1|2013-02-27|2016-01-07|Toyota Jidosha Kabushiki Kaisha|Method for producing ethanol using recombinant yeast|
    EP2970863B1|2013-03-14|2019-04-24|E. I. du Pont de Nemours and Company|Glycerol 3- phosphate dehydrogenase for butanol production|
    US9850512B2|2013-03-15|2017-12-26|The Research Foundation For The State University Of New York|Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield|
    WO2014151318A2|2013-03-15|2014-09-25|Mascoma Corporation|Methods for regulating nitrogen metabolism during the production of ethanol from corn by metabolically engineered yeast strains|
    WO2014180820A2|2013-05-08|2014-11-13|Dsm Ip Assets B.V.|Gpd- yeast strains with improved osmotolerance|
    AR097480A1|2013-08-29|2016-03-16|Dsm Ip Assets Bv|GLYCEROL AND ACETIC ACID CONVERTER YEAST CELLS WITH AN IMPROVED ACETIC ACID CONVERSION|
    CN105722969A|2013-10-28|2016-06-29|丹尼斯科美国公司|Large scale genetically engineered active dry yeast|
    KR102255306B1|2013-11-15|2021-05-25|삼성전자주식회사|Genetically engineered yeast cell producing lactate comprising acetaldehyde dehydrogenase, method of producing yeast cell and method of producing lactate using the same|
    US9951363B2|2014-03-14|2018-04-24|The Research Foundation for the State University of New York College of Environmental Science and Forestry|Enzymatic hydrolysis of old corrugated cardboardfines from recycled linerboard mill waste rejects|
    CN107208036A|2014-03-21|2017-09-26|诺维信公司|Method for producing ethanol and yeast|
    WO2015148272A1|2014-03-28|2015-10-01|Danisco Us Inc.|Altered host cell pathway for improved ethanol production|
    KR20160012561A|2014-07-24|2016-02-03|삼성전자주식회사|Genetically engineered and acid resistant yeast cell with enhanced ERG5 activity and method for producing lactate using the same|
    WO2016153924A1|2015-03-20|2016-09-29|Novozymes A/S|Processes for producing ethanol and ethanol producing yeast|
    WO2016188813A1|2015-05-22|2016-12-01|Dsm Ip Assets B.V.|Acetate consuming yeast cell|
    CA2998981A1|2015-10-06|2017-04-13|Ioannis PAPAPETRIDIS|Eukaryotic cell with increased production of fermentation product|
    US20190338256A1|2016-04-28|2019-11-07|Danisco Us Inc.|Redox balancing in yeast|
    BR112018074490A2|2016-06-14|2019-03-19|Dsm Ip Assets B.V.|recombinant yeast cell|
    JP6447583B2|2016-06-24|2019-01-09|トヨタ自動車株式会社|Recombinant yeast and method for producing ethanol using the same|
    WO2018089333A1|2016-11-09|2018-05-17|Danisco Us Inc.|Yeast with improved alcohol production|
    CA3047268A1|2016-12-16|2018-06-21|Danisco Us Inc.|Bifunctional phosphoketolase-phosphotransacetylase fusion polypeptides|
    EP3559246A1|2016-12-20|2019-10-30|DSM IP Assets B.V.|Improved yeast strains for ethanol production|
    US20190382739A1|2017-01-18|2019-12-19|Danisco Us Inc.|Modified yeast cells that overexpress a dna polymerase subunit|
    BR112019019701A2|2017-03-24|2020-07-14|Danisco Us Inc.|reduction of acetate and glycerol in modified yeast that has an exogenous ethanol production path|
    CN110678545A|2017-04-17|2020-01-10|丹尼斯科美国公司|Selected acetyl-CoA synthases for reducing acetate production in yeast|
    US20200131591A1|2017-06-06|2020-04-30|Danisco Us Inc.|Yeast with improved alcohol production|
    CA3064143A1|2017-06-13|2018-12-20|Dsm Ip Assets B.V.|Recombinant yeast cell|
    JP6879111B2|2017-08-02|2021-06-02|トヨタ自動車株式会社|Recombinant yeast and method for producing ethanol using it|
    UY37835A|2017-08-08|2019-03-29|Danisco Us Inc|INCREASED PRODUCTION OF ETHANOL BY LEAVES WHICH HAVE ALELOS OF THE EVIL CONSTITUTIONAL TRANSCRIPTION ACTIVATOR|
    BR112020004021A2|2017-08-29|2020-09-08|Danisco Us Inc.|modified yeast comprising glucose-specific atp-mediated transporters|
    CN111133111A|2017-09-26|2020-05-08|帝斯曼知识产权资产管理有限公司|Acetic acid consuming strains|
    CA3073329A1|2017-09-26|2019-04-04|Dsm Ip Assets B.V.|Improved process for ethanol production|
    EP3688170A1|2017-09-29|2020-08-05|DSM IP Assets B.V.|Improved glycerol free ethanol production|
    BR112020008023A2|2017-10-24|2020-10-13|Danisco Us Inc.|yeast with improved alcohol production|
    WO2019110492A1|2017-12-08|2019-06-13|Dsm Ip Assets B.V.|Recombinant yeast cell|
    WO2019110491A1|2017-12-08|2019-06-13|Dsm Ip Assets B.V.|Recombinant yeast cell|
    BR112020018055A2|2018-03-06|2020-12-29|Danisco Us Inc.|REDUCTION IN ACETATE PRODUCTION THROUGH YEAST THAT OVEREXPRESSED PAB1|
    US20210040474A1|2018-03-06|2021-02-11|Danisco Us Inc.|Yeast with improved alcohol production under high dissolved solids conditions|
    WO2019173217A1|2018-03-06|2019-09-12|Danisco Us Inc|Compositions and methods for increasing ethanol production by yeast using gcy1 and dak1|
    WO2019195382A1|2018-04-06|2019-10-10|Danisco Us Inc|Increased alcohol production from yeast producing an increased amount of active hac1 protein|
    UY38179A|2018-04-12|2019-11-29|Danisco Us Inc|YEAST THAT OVER EXPRESSES PROTEIN PHOSPHATASES ASSOCIATED WITH THE HOG PATHWAY|
    CN112513261A|2018-05-25|2021-03-16|丹尼斯科美国公司|Overexpression of fumarate reductase leads to increased fermentation rates in yeast|
    WO2019231743A1|2018-05-30|2019-12-05|Danisco Us Inc|Over-expression of transcriptional activator/repressor gis1 in yeast for increased ethanol production|
    BR112021001577A2|2018-07-27|2021-04-20|Danisco Us Inc.|increased alcohol production from yeast that produces an increased amount of active crz1 protein|
    US20210332091A1|2018-09-28|2021-10-28|Danisco Us Inc|Over-expression of gds1 in yeast for increased ethanol and decreased acetate production|
    WO2020068907A1|2018-09-28|2020-04-02|Danisco Us Inc|Selected phosphotransacetylase genes for increased ethanol production in engineered yeast|
    US20210395756A1|2018-09-28|2021-12-23|Danisco Us Inc|Over expression of ribonucleotide reductase inhibitor in yeast for increased ethanol production|
    BR112021013257A2|2019-01-08|2021-09-14|Danisco Us Inc.|HYBRID YEAST WITH INCREASED ETHANOL PRODUCTION|
    CN113795503A|2019-03-14|2021-12-14|丹尼斯科美国公司|Cytochrome B2 overexpression in yeast for increasing ethanol production|
    WO2020186254A1|2019-03-14|2020-09-17|Danisco Us Inc|Over-expression of fumarate-succinate transporter in yeast for increased ethanol and reduced acetate production|
    WO2020263732A1|2019-06-24|2020-12-30|Danisco Us Inc|Disruption of cdc42 effectors in yeast for increased alcohol and lysine production|
    AU2020301126A1|2019-06-24|2022-01-27|Danisco Us Inc|Modified yeast and method for increasing lysine content in fermentation co-products|
    CA3145108A1|2019-06-28|2020-12-30|Jaclyn Diana DEMARTINI|Modified yeast cells that over-express selected endogenous proteins|
    WO2021022140A1|2019-08-01|2021-02-04|Danisco Us Inc|Over-expression of pho13 for increased ethanol production by yeast|
    WO2021022097A1|2019-08-01|2021-02-04|Danisco Us Inc|Over-expression of adh5p for increased ethanol production by yeast|
    WO2021041141A1|2019-08-29|2021-03-04|Danisco Us Inc|Expression of beta-glucosidase in yeast for improved ethanol production|
    WO2021089877A1|2019-11-08|2021-05-14|Dsm Ip Assets B.V.|Process for producing ethanol|
    WO2021108464A1|2019-11-26|2021-06-03|Danisco Us Inc.|Reduction in acetate production by yeast over-expressing mig polypeptides|
    WO2021150911A1|2020-01-23|2021-07-29|Danisco Us Inc|Increased ethanol production by overexpression of jid1 in yeast|
    法律状态:
    2015-06-23| B27A| Filing of a green patent (patente verde) [chapter 27.1 patent gazette]|
    2015-07-14| B27B| Request for a green patent granted [chapter 27.2 patent gazette]|
    2015-08-04| B25A| Requested transfer of rights approved|Owner name: DSM IP ASSETS B.V (NL) |
    2015-08-18| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2015-12-29| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2016-04-12| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|
    2016-08-23| B09B| Patent application refused [chapter 9.2 patent gazette]|Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24 E 25 DA LPI. |
    2016-12-06| B12B| Appeal against refusal [chapter 12.2 patent gazette]|
    2018-09-11| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/07/2010, OBSERVADAS AS CONDICOES LEGAIS. |
    优先权:
    申请号 | 申请日 | 专利标题
    EP09166360A|EP2277989A1|2009-07-24|2009-07-24|Fermentative glycerol-free ethanol production|
    PCT/NL2010/050475|WO2011010923A1|2009-07-24|2010-07-23|Fermentative glycerol-free ethanol production|
    [返回顶部]